MEIS-1 level in unresectable hepatocellular carcinoma can predict the post-treatment outcomes of radiofrequency ablation.
about
Novel ADAM-17 inhibitor ZLDI-8 enhances the in vitro and in vivo chemotherapeutic effects of Sorafenib on hepatocellular carcinoma cells.MicroRNA-140-3p enhances the sensitivity of hepatocellular carcinoma cells to sorafenib by targeting pregnenolone X receptorMicroRNA-645 targets urokinase plasminogen activator and decreases the invasive growth of MDA-MB-231 triple-negative breast cancer cells
P2860
MEIS-1 level in unresectable hepatocellular carcinoma can predict the post-treatment outcomes of radiofrequency ablation.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
MEIS-1 level in unresectable h ...... es of radiofrequency ablation.
@en
MEIS-1 level in unresectable h ...... es of radiofrequency ablation.
@nl
type
label
MEIS-1 level in unresectable h ...... es of radiofrequency ablation.
@en
MEIS-1 level in unresectable h ...... es of radiofrequency ablation.
@nl
prefLabel
MEIS-1 level in unresectable h ...... es of radiofrequency ablation.
@en
MEIS-1 level in unresectable h ...... es of radiofrequency ablation.
@nl
P2093
P2860
P356
P1433
P1476
MEIS-1 level in unresectable h ...... es of radiofrequency ablation.
@en
P2093
Haipeng Yu
Huaming Wang
Shengtao Tian
Ximing Wang
Xueling Yang
P2860
P304
15252-15265
P356
10.18632/ONCOTARGET.24165
P407
P577
2018-01-11T00:00:00Z